Chronic migraine is a highly disabling and difficult to treat form of migraine. In this thesis, various clinical aspects and the management of chronic migraine are investigated, in order to enhance prevention and treatment of chronic migraine. Important risk factors for chronic migraine are depression, anxiety, cutaneous allodynia and especially overuse of acute anti-headache medication. The studies in this thesis conform that withdrawal of the overused medication results into a meaningful improvement in many patients. A double-blind randomised controlled trial did not show any additional benefit of treatment with Botulinum toxin A adjacent to acute withdrawal. Another double-blind randomised controlled trial did suggest effectiveness of a ...
Introduction: OnabotulinumtoxinA (BT-A) is a preventive treatment for chronic migraine (CM), which n...
Chronic migraine (CM) is defined as headache occurring on 15 or more days per month for more than th...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5-2 % of the population. In ...
Migraine is highly prevalent and carries a significant personal, social and economic burden. It is t...
Migraine is an episodic painful disorder which can gradually chronify, and is among the most common ...
Chronic migraine is a disabling neurological disorder that imposes a considerable burden on individu...
Chronic migraine as a disease was initially recognized in patients with a large burden of disability...
Chronic migraine is often complicated by medication-overuse headache (MOH), a headache due to excess...
Migraine is an episodic painful disorder occasionally developing into a chronic form. Such disorder ...
Migraine is a very common neurologic disorder, characterized by recurrent attacks of severe headache...
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelo...
Chronic headaches have increasingly become a focus within the field of head pain. For the most part ...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5-2 % of the population. In ...
Chronic Migraine (CM) is a disabling neurologic condition with a severe impact on functioning and qu...
Chronic migraine (CM) is one of the most disabling diseases, and it is commonly misdiagnosed and mis...
Introduction: OnabotulinumtoxinA (BT-A) is a preventive treatment for chronic migraine (CM), which n...
Chronic migraine (CM) is defined as headache occurring on 15 or more days per month for more than th...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5-2 % of the population. In ...
Migraine is highly prevalent and carries a significant personal, social and economic burden. It is t...
Migraine is an episodic painful disorder which can gradually chronify, and is among the most common ...
Chronic migraine is a disabling neurological disorder that imposes a considerable burden on individu...
Chronic migraine as a disease was initially recognized in patients with a large burden of disability...
Chronic migraine is often complicated by medication-overuse headache (MOH), a headache due to excess...
Migraine is an episodic painful disorder occasionally developing into a chronic form. Such disorder ...
Migraine is a very common neurologic disorder, characterized by recurrent attacks of severe headache...
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelo...
Chronic headaches have increasingly become a focus within the field of head pain. For the most part ...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5-2 % of the population. In ...
Chronic Migraine (CM) is a disabling neurologic condition with a severe impact on functioning and qu...
Chronic migraine (CM) is one of the most disabling diseases, and it is commonly misdiagnosed and mis...
Introduction: OnabotulinumtoxinA (BT-A) is a preventive treatment for chronic migraine (CM), which n...
Chronic migraine (CM) is defined as headache occurring on 15 or more days per month for more than th...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5-2 % of the population. In ...